Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
A clinical trial is investigating whether Galectin-3 levels predict outcomes in patients with renal cell carcinoma, urothelial carcinoma, no…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
UmbREALung is a real-world, observational study in non-small cell lung cancer patients initiating approved AstraZeneca drugs or AZ Alliance …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Boosting Osimertinib Blood Brain Barrier Penetration [Phase 2]
A Phase 2 clinical trial update from Maastricht University Medical Center describes efforts to boost brain penetration of osimertinib in non…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy [Phase 2]
Phase 2 pilot study comparing outcomes of performance status 2 vs 0-1 in non-small cell lung cancer patients treated with chemotherapy and i…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC. [Phase 4]
A ClinicalTrials.gov update describes a Phase 4 trial of combining osimertinib with chemotherapy for distant recurrence after adjuvant osime…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）
This clinical trial investigates predicting outcomes of neoadjuvant therapy in non-small cell lung cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases [Phase 2]
Phase 2 clinical trial evaluating prophylactic anti-seizure medication versus no anti-seizure medication in patients with primary motor cort…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Clinical Outcomes and Quality Of Life After Minimally Invasive Segmentectomy Versus Lobectomy for Lung Cancer
A clinical trial comparing minimally invasive segmentectomy to lobectomy for non-small cell lung cancer to evaluate clinical outcomes and qu…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction [Phase 2]
Phase 2 clinical trial evaluating same-day planning and margin-reduced stereotactic radiation for growing or changing brain metastases. The …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Fiber-Boost Randomized Controlled Trial [NA]
Clinical trial update shows a fiber-boost randomized controlled trial for non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors [Phase 1]
This update reports on a Phase 1 trial testing the combination of sonidegib and pembrolizumab in patients with various advanced solid tumors…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Regeneron is evaluating REGN5093 in adults with MET-altered advanced non-small cell lung cancer in a Phase 1/2 study. The trial status is re…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification [Phase 1]
BeiGene is conducting a first-in-human Phase 1 study of BGB-53038, a pan-KRAS inhibitor, as a monotherapy or in combination, in participants…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors [Phase 1, Phase 2]
Roche is conducting a dose-escalation Phase 1/2 trial of a PD-1/LAG-3 bispecific antibody in patients with advanced or metastatic solid tumo…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Effect of Pre-operative Exercise Training on Cardiorespiratory Fitness in Patients With Locally Advanced Non-small Cell Lung Cancer Undergoing Induction Chemo-immunotherapy Followed by Surgery - a Randomized Controlled Study [NA]
This clinical trial registry entry describes a randomized controlled study to assess whether pre-operative exercise training improves cardio…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Clinical trial update on paclitaxel therapeutic drug monitoring in cancer patients; the study is currently suspended.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers [Phase 1, Phase 2]
A clinical trial update describing STK-012 alone or in combination for advanced lung cancer and other solid tumors, currently recruiting in …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
A clinical trial update indicates recruitment is ongoing for a multi-omics study of early-stage lung cancer with distinct phenotypes, includ…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation [Phase 1, Phase 2]
Novartis reports an update on the JDQ-443 clinical program in advanced KRAS G12C-mutant solid tumors, including non-small cell lung cancer a…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for FMC-376 in KRAS G12C-mutated solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing SGN-B6A to docetaxel in previously treated non-small cell lung cancer is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC [NA]
Clinical trial update describing a study of Progel Platinum to reduce air leaks after VATS lobectomy in non-small cell lung cancer; the tria…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004) [Phase 3]
Phase 3 trial evaluating eftilagimod alfa in combination with pembrolizumab and chemotherapy versus placebo with pembrolizumab and chemother…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples [NA]
This clinical trial update describes a study at University Hospital Tours examining immune responses to immunotherapy in non-small cell lung…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer. [Phase 3]
Global Phase 3 trial comparing Volrustomig plus chemotherapy versus pembrolizumab plus chemotherapy in metastatic non-small cell lung cancer…